NCT02845323: Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder
- State
- Under way
- Phase
- Phase 2
- People
- 15 taking part
- Started
- 16 May 2017
- Primary completion
- 31 Jul 2027
- Arms
- Nivolumab in combination with Urelumab
- Results
- None posted
- 27 Jul 2016: Trial registered
- 16 May 2017: Trial started